Maidenhead, United Kingdom

Sam Mansoor

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Lonza Biologics Plc. Active years: 2014-2019.


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Sam Mansoor in Polypeptide Purification

Introduction

Sam Mansoor is an accomplished inventor based in Maidenhead, GB. He has made significant contributions to the field of biotechnology, particularly in the purification of polypeptides. With a total of two patents to his name, Mansoor's work is recognized for its innovative approaches and practical applications.

Latest Patents

Mansoor's latest patents include a method and system for polypeptide purification. This invention provides an automated system for the purification of polypeptides, which includes the direct filtration of solutions containing the polypeptides after purification. This advancement is crucial for enhancing the efficiency and effectiveness of polypeptide purification processes.

Career Highlights

Sam Mansoor is currently employed at Lonza Biologics Plc, a leading company in the biotechnology sector. His role at Lonza allows him to apply his expertise in developing innovative solutions for complex biological challenges. His contributions have been instrumental in advancing the company's capabilities in biopharmaceutical manufacturing.

Collaborations

Mansoor collaborates with various professionals in his field, including his coworker Mark R Whickman. Together, they work on projects that aim to push the boundaries of current biotechnological practices.

Conclusion

Sam Mansoor's work in polypeptide purification exemplifies the innovative spirit of modern biotechnology. His patents reflect a commitment to improving purification methods, which are essential for the advancement of biopharmaceuticals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…